G
GLP1 Lawsuit
Mass Tort Case Review
Call
GLP-1 Drug Injury

Zepbound Lawsuit

Zepbound is Eli Lilly's tirzepatide injection approved for chronic weight management. It shares the active ingredient and side-effect profile of Mounjaro and is included in the consolidated GLP-1 litigation.

Call (717) 724-7503

Free Confidential Case Review

No fee unless you win. Takes under 60 seconds.

Zepbound injuries

Plaintiffs allege Zepbound caused gastroparesis, severe pancreatitis, intestinal obstruction, gallbladder disease, and other gastrointestinal injuries — and that Eli Lilly failed to provide adequate warnings.

Do you qualify?

Documented use of Zepbound plus a hospitalized or formally diagnosed qualifying injury, without prior history, generally supports a claim. A free case review will confirm.

Frequently Asked Questions

Get your free, confidential case review

Takes under 60 seconds. No fee unless you win.

Free Confidential Case Review

No fee unless you win. Takes under 60 seconds.